BIOVIA is launching a brand new Drug Discovery & Development Community
Why? Because we are at a unique time in history with cheminformatics and modeling & simulation methods now combining with Artificial Intelligence/Machine Learning to advance molecular discovery and optimization.
BIOVIA believes that bringing researchers from these disciplines together is the key to accelerating new breakthroughs in data-driven science.
Improve Towards a Target Product Profile
In drug discovery, scientists now explore chemical space by “learning” from real experiments. The enumeration of all molecules that could be drugs is not currently possible with reasonable resources. However, chemists can use AI and machine learning to explore a large area of chemical space through an iterative generative design process with a fitness function that represents the target product profile. The discovery cycle combines virtual and real (V+R) activities in which the results of virtual generation and evaluation combine with real world synthesis and testing to allow active learning.
Novel molecules advanced by the virtual ‘generate-test-score’ pruning process move to the lab for synthesis and screening. Real world screening results allow the update of predictive models for subsequent cycles. Optimization of all objectives continues until the target therapeutic profile is met. This iterative V+R cycle accelerates lead candidate design with improved quality, significantly reducing costs of experimentation and advancing only the most promising candidates to clinical trials.
Collaborate More Effectively in Drug Discovery & Development
Your new Drug Discovery and Development Community will provide updates about BIOVIA technology and events. Share ideas about the use of BIOVIA products and research approaches. Pose questions to the community at large. Share content with others, for example: “How to” videos, BIOVIA Pipeline Pilot protocols and BIOVIA Insight/BIOVIA Draw plug-ins to extend existing product functionality.
The new Community addresses the needs of customers using the following BIOVIA applications: Generative Therapeutics Design, Discovery Studio, Registration, Insight and Insight for Excel, Direct Cartridge, Draw, Pipette Sketcher, Pipeline Pilot Chemistry Collection/SDK, BIOVIA Content and DiscoveryGate.
To become an active participant in this new Community, subscribe to the daily digest by emailing tien.luu@3ds.com.
Digest subscribers will receive an automated email from BIOVIA each day there is activity in the community.
BIOVIA Drug Discovery & Development Community
Tien Luu is the Product Manager and Principal Scientific Specialist at BIOVIA Dassault Systèmes, managing aspects of life science modeling and simulation predictive science solutions. She began her career as a Scientific Specialist after receiving her Ph.D. in Chemistry from the University of Wollongong, Australia. Since joining BIOVIA 22 years ago, Tien’s passion and excitement for helping customers accelerate their R&D have been steadfast and she is committed to improve customer experiences and product successes. In addition, she continues to be an active leader in scientific software product development, new program initiatives, and new applied and fundamental scientific research.